WADDILL WILLIAM D. sold 53.5% of their position (9K shares) of PROTAGONIST THERAPEUTICS, INC on the open market
Open‑market sale worth $969.1K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/11/2026ACC: 0001104659-26-073049
Director
Since Jun 2019
-9K
Net shares
Net seller
$969.1K
Total sold
1
Open market trades
0B · 1S
5
Total transactions
9K acquired · 18K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+3K
Price / share
$11.80
Trade value
$35.40K
% of position
38.3%
6/10/2026
7.83K→10.82K
Common Stock
Direct
Shares
+6K
Price / share
$16.54
Trade value
$99.24K
% of position
55.4%
6/10/2026
10.82K→16.82K
Common Stock
Direct
Shares
−9K
Price / share
$107.68
Trade value
$969.12K
% of position
53.5%
6/10/2026
16.82K→7.83K
Total
Net shares
+0.00
Net value
-$834.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/10/2026 | M · Option Exercise | +3K | $11.80 | $35.40K | 38.3% | 7.83K | 10.82K |
| Common Stock Direct | 6/10/2026 | M · Option Exercise | +6K | $16.54 | $99.24K | 55.4% | 10.82K | 16.82K |
| Common Stock Direct | 6/10/2026 | S · Sale | −9K | $107.68 | $969.12K | 53.5% | 16.82K | 7.83K |
| Total | +0.00 | -$834.48K | ||||||
Derivative Transactions2
Stock Option (right to buy)
Direct
Converts to
Common Stock
3K shares
Shares
−3K
Strike price
11.8
Held after
0.00
Exercisable
—
6/10/2026
Stock Option (right to buy)
Direct
Converts to
Common Stock
6K shares
Shares
−6K
Strike price
16.54
Held after
9K
Exercisable
—
6/10/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock3K shares | 6/10/2026 | M · Option Exercise | −3K | 11.8 | — | 0.00 |
| Stock Option (right to buy) Direct | Common Stock6K shares | 6/10/2026 | M · Option Exercise | −6K | 16.54 | — | 9K |